Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance

新冠肺炎住院患者病毒清除的免疫决定因素:循环中初始CD4+ T细胞计数降低与病毒清除延迟相关

阅读:1
作者:Mihaela Zlei ,Igor A Sidorov ,Simone A Joosten ,Mirjam H M Heemskerk ,Sebenzile K Myeni ,Cilia R Pothast ,Caroline S de Brouwer ,A Linda Boomaars-van der Zanden ,Krista E van Meijgaarden ,Shessy T Morales ,Els Wessels ,Jacqueline J Janse ,Jelle J Goeman ,Christa M Cobbaert ,Aloys C M Kroes ,Suzanne C Cannegieter ,Meta Roestenberg ,Leonardus G Visser ,Marjolein Kikkert ,Mariet C W Feltkamp ,Sesmu M Arbous ,Frank J T Staal ,Tom H M Ottenhoff ,Jacques J M van Dongen ,Anna H E Roukens ,Jutte J C de Vries ,In Collaboration With Beat-Covid, In Collaboration With Lumc Covid

Abstract

Virus-specific cellular and humoral responses are major determinants for protection from critical illness after SARS-CoV-2 infection. However, the magnitude of the contribution of each of the components to viral clearance remains unclear. Here, we studied the timing of viral clearance in relation to 122 immune parameters in 102 hospitalised patients with moderate and severe COVID-19 in a longitudinal design. Delayed viral clearance was associated with more severe disease and was associated with higher levels of SARS-CoV-2-specific (neutralising) antibodies over time, increased numbers of neutrophils, monocytes, basophils, and a range of pro-inflammatory cyto-/chemokines illustrating ongoing, partially Th2 dominating, immune activation. In contrast, early viral clearance and less critical illness correlated with the peak of neutralising antibodies, higher levels of CD4 T cells, and in particular naïve CD4+ T cells, suggesting their role in early control of SARS-CoV-2 possibly by proving appropriate B cell help. Higher counts of naïve CD4+ T cells also correlated with lower levels of MIF, IL-9, and TNF-beta, suggesting an indirect role in averting prolonged virus-induced tissue damage. Collectively, our data show that naïve CD4+ T cell play a critical role in rapid viral T cell control, obviating aberrant antibody and cytokine profiles and disease deterioration. These data may help in guiding risk stratification for severe COVID-19.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。